Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2000

Study Completion Date

August 31, 2009

Conditions
Lymphoma
Interventions
DRUG

liposomal vincristine sulfate

Trial Locations (9)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

60612

University of Illinois at Chicago, Chicago

62526

Decatur Memorial Hospital Cancer Care Institute, Decatur

75708

University of Texas Health Center at Tyler, Tyler

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

05401-3498

Vermont Cancer Center, Burlington

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

Sponsors
All Listed Sponsors
lead

Inex Pharmaceuticals

INDUSTRY